These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 6014586)
1. [Experimental studies on bamfolin for its cancerotoxic effect]. Osswald H Arzneimittelforschung; 1966 Jun; 16(6):746-8. PubMed ID: 6014586 [No Abstract] [Full Text] [Related]
2. [Effect of aminomethylating carcinostatics on experimental animal tumors. IV. On cytostatics]. Schönenberger H; Adam A; Adam D Arzneimittelforschung; 1966 Jun; 16(6):734-8. PubMed ID: 6014584 [No Abstract] [Full Text] [Related]
3. [Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse]. Zeller WJ; Wiessler M; Adzersen KH Arzneimittelforschung; 1972 Mar; 22(3):575-7. PubMed ID: 5067931 [No Abstract] [Full Text] [Related]
4. A study on the sensitivity test of cancer cells to anticancer drugs. Fukushima M; Ishikawa Y; Horimai T; Adachi M Tohoku J Exp Med; 1966 Jul; 89(3):251-64. PubMed ID: 4290932 [No Abstract] [Full Text] [Related]
5. [Studies with Proresid (SP-I) in various innoculation tumors]. Osswald H; Schmähl D Med Klin; 1966 Apr; 61(17):681-4. PubMed ID: 5995181 [No Abstract] [Full Text] [Related]
6. Variations in carbohydrate-metabolizing activities of ascites tumor cells during growth in vivo. Tsuiki S; Sukeno T; Saheki R; Takeda R Sci Rep Res Inst Tohoku Univ Med; 1966 Dec; 13(3):223-8. PubMed ID: 5984022 [No Abstract] [Full Text] [Related]
7. In vitro test for sensitivity of tumor to carcinostatic agents. Kondo T; Imamura T; Ichihashi H Gan; 1966 Apr; 57(2):113-21. PubMed ID: 4289605 [No Abstract] [Full Text] [Related]
8. Different uptake of two alkylating substances by ascites tumor cells. Schmidt H; Liss E Arzneimittelforschung; 1978; 28(11):2150-2. PubMed ID: 582920 [TBL] [Abstract][Full Text] [Related]
9. [Remarkable antimitotic action of watercress (Nasturtium officinales) on some experimental tumors]. Cruz A Hospital (Rio J); 1970 Mar; 77(3):943-52. PubMed ID: 5315123 [No Abstract] [Full Text] [Related]
10. Influence of the chemical structure on the biological endency of cytostatic compounds related to dibromomannitol. I. Structure-activity correlations. Institóris L; Horváth IP; Csányi E Arzneimittelforschung; 1967 Feb; 17(2):145-9. PubMed ID: 5631481 [No Abstract] [Full Text] [Related]
12. [Nucleolus changes in malignancy]. Janisch H; Michalica W Wien Klin Wochenschr; 1970 Sep; 82(36):615-7. PubMed ID: 5515809 [No Abstract] [Full Text] [Related]
13. [Studies on the effect of 6-azauracilriboside in the irradiation of experimental animal tumors]. Magdon ; Konopatzky R Arch Geschwulstforsch; 1967; 29(3):259-65. PubMed ID: 5595236 [No Abstract] [Full Text] [Related]
14. Antineoplastic activity of diazoacetyl-glycine derivatives. Baldini L; Brambilla G Cancer Res; 1966 Aug; 26(8):1754-8. PubMed ID: 5923173 [No Abstract] [Full Text] [Related]
15. [Additional classes of tumor inhibiting compounds. V. Cytostatic properties of alkylated alcohols and aldehydes of the chain length C 8 ]. Weitzel G; Jackisch R; Meier-Gerwert H; Zinser D Hoppe Seylers Z Physiol Chem; 1972 Apr; 353(4):641-53. PubMed ID: 5053443 [No Abstract] [Full Text] [Related]
17. [The studies on anerobic glycolysis and the inhibition of lactic acid production in Ehrlich's ascites carcinoma by anticancer agents]. Koga H Kumamoto Igakkai Zasshi; 1971 Feb; 45(2):169-99. PubMed ID: 5109085 [No Abstract] [Full Text] [Related]
18. EXPERIMENTAL INVESTIGATIONS INTO THE ANTITUMORAL ACTIVITY OF 1,2,5,6-TETRAHYDROMETHANE-SULPHONYL-D-MANNITOL (TSM). KENDREY G; BALO J; JUHASZ J; GYENES G; SELLYEI M Acta Unio Int Contra Cancrum; 1964; 20():141-3. PubMed ID: 14151869 [No Abstract] [Full Text] [Related]
19. [The influence of 4-hydroxypentenal on the content of protein-bound and not-protein-bound SH-groups in normal and tumor cells]. Rindler R; Schauenstein E Z Naturforsch B; 1970 Jul; 25(7):739-44. PubMed ID: 4394214 [No Abstract] [Full Text] [Related]
20. Cytembena administered in combination with cyclophosphamide in Yoshida ascitic sarcoma. Veselá H; Jelínek V; Pujman V; Zlatkovská Z Neoplasma; 1971; 18(5):459-64. PubMed ID: 5119519 [No Abstract] [Full Text] [Related] [Next] [New Search]